Effectiveness of Pharmaceutical Care on Primary Care Patients With Uncontrolled Hypertension

NCT00807131 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 301

Last updated 2008-12-11

No results posted yet for this study

Summary

This randomized clinical trial is a multicentre study conducted at 4 community-based pharmacies within the Brazilian public health service, which freely distributes standardized medicines. The group coordinator is located at the Universidade Federal do Rio Grande do Sul, a public university at Porto Alegre.

Conditions

Interventions

BEHAVIORAL

Patient follow-up

Dader method, which was developed to provide pharmaceutical care, which consists of seven steps covering the evaluation of services, benefits of interventions, and identification of unexpected occurrences. Its objectives are to improve the patient quality of life.

BEHAVIORAL

Counseling

The pharmacist proceeds the counseling when the patient comes to the pharmacy to take their medicines.

BEHAVIORAL

Drug dispensing

The pharmacist gives the drugs to the patient with the minimum of information necessary to guarantee a safe and effective drug intake.

BEHAVIORAL

pharmacy usual care

The patient receives no information about their medicines in the pharmacy, unless he asks for it.

Sponsors & Collaborators

  • Hospital de Clinicas de Porto Alegre

    lead OTHER

Principal Investigators

  • Mauro Castro, PhD · Federal University of Health Science of Porto Alegre

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-09-30
Primary Completion
2008-08-31
Completion
2008-08-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00807131 on ClinicalTrials.gov